1. A multicentre prospective study response to treatment in genotype 3 and 1b infected patients with sickest liver cirrhosis: SVR 4 is not a reliable measure. (8th October 2016) Authors: Persico, M.; Rendina, M.; Di Marco, V.; Aghemo, A.; Brunetto, M.; Ciancio, A.; Zuin, M.; Andreone, P.; Villa, E.; Calvaruso, V.; De Nicola, S.; Coco, B.; Aglitti, A.; Toshina, Y.; Giorgini, A.; Conti, F.; Marzi, L.; Lleo, A.; Bollani, S.; Di Leo, A. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection. (February 2019) Authors: Di Marco, L.; Calvaruso, V.; Grimaudo, S.; Petta, S.; Pipitone, M.R.; Cabibbo, G.; Conte, E.; Magro, B.; Rini, F.; Celsa, C.; Cammà, C.; Craxì, A.; Di Marco, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.87 RESIST-HCV CRITERIA ARE ABLE TO RULE OUT ESOPHAGEAL VARICES PROGRESSION IN PATIENTS WITH HCV CIRRHOSIS TREATED BY DIRECT-ACTING ANTIVIRAL AGENTS(DAAS). (September 2021) Authors: Calvaruso, V.; Petta, S.; Licata, M.; Simone, F.; Di Marco, L.; Crapanzano, L.; Di Martino, V.; Abdel Hadi, Y.; Cammà, C.; Craxì, A.; Di Marco, V. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in 13C-aminopyrine breath test predict liver-related events and death in patients with HCV-related previous decompensated child A5 or child A6 to B cirrhosis who achieve SVR after DAA therapy. (February 2019) Authors: Petta, S.; Rini, F.; Calvaruso, V.; Cammà, C.; Ciminnisi, S.; Di Marco, V.; Giannini, E.; Grimaudo, S.; Pipitone, R.M.; Craxì, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Lenci, I.; Aragri, M.; Polilli, E.; Fiorentino, G.; Pace Palitti, V.; Bruzzone, B.; Paolucci, S.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Niero, F.; Micheli, V.; Nicolini, L.A.; Marenco, S.; Bertoli, A.; Maida, I.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Current epidemiology of HCV in Sicily: the RESIST-HCV model. (October 2019) Authors: Di Marco, V.; Cartabellotta, F.; Mazzucco, W.; Calvaruso, V.; Petta, S.; Mazzola, S.; Cusimano, R.; Amodio, R.; Scifo, G.; Russello, M.; Cacopardo, B.; Squadrito, G.; Raimondo, G.; Pollicino, T.; Ceccherini-Silbertein, F.; Vitale, F.; Cammà, C.; Craxì, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 3 Page Start: e262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. (February 2019) Authors: Cabibbo, G.; Celsa, C.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort. Issue 1 (February 2018) Authors: Calvaruso, V.; Petta, S.; Cacciola, I.; Cabibbo, G.; Cartabellotta, F.; Di Rosolini, A.; Davì, A.; Cannavò, M.; Russello, M.; Distefano, M.; Scifo, G.; Di Lorenzo, F.; Prestileo, T.; La Rocca, L.; Montineri, A.; Fiduli, G.; Digiacomo, A.; Cannizzaro, M.; Madonia, S.; Licata, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs). Issue 1 (16th February 2017) Authors: Calvaruso, V.; Cabibbo, G.; Cacciola, I.; Petta, S.; Madonia, S.; Bellia, A.; Tinè, F.; Distefano, M.; Giannitrapani, L.; Prestileo, T.; Mazzola, G.; Davì, A.; Larocca, L.; Ardiri, A.; Digiacomo, A.; Gussio, M.; Guarneri, L.; Magro, A.; Averna, A.; Iacobello, C. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗